Greg Durm, Md

This study looked at whether giving immunotherapy drugs (nivolumab alone or with ipilimumab) after standard chemoradiation can help people with stage III lung cancer that cannot be removed by surgery. About 105 participants were enrolled. The goal was to see if these treatments c…